{
    "summary": "Aiming to Improve the Lives of Patients with ACLF and Other Life-Threatening Liver Diseases - GENFIT is a late-stage biopharmaceutical Company dedicated to improving the lives of patients with rare and life-threatening liver diseases characterized by high unmet medical needs. They are a pioneer in the discovery and development of drugs targeting liver diseases, with a longstanding history and strong scientific heritage spanning more than two decades. They have expertise in Acute-on-Chronic Liver Failure (ACLF) and its associated medical complications, with five assets in development based on differentiated mechanisms of action leveraging complementary pathways.\n\n"
}